MDGL Should I Buy
-
$
0.000
0.000(0.000%)
At close0.000(0.000%)Aft-market
ET
Loading...
Madrigal Pharmaceuticals (MDGL) is not a strong buy for a beginner, long-term investor at this moment. While the company shows strong revenue growth and has potential in its MASH opportunity, the mixed analyst ratings, insider selling, and lack of clear technical or proprietary trading signals suggest waiting for a more favorable entry point. The pre-market price of $436.6 is near a key support level, but no strong upward momentum is evident.
The MACD is below 0 and negatively contracting, indicating bearish momentum. RSI is neutral at 42.017, and moving averages are converging, showing no clear trend. The stock is trading near its S1 support level of 430.798, with resistance at 459.028. Overall, technical indicators suggest a lack of strong upward momentum.
Hedge funds are increasing their positions, with a 176.46% rise in buying activity. Analyst coverage includes some positive ratings, such as Barclays' Overweight rating with a $964 price target, and Piper Sandler's increased conviction in REZDIFFRA's potential. Revenue growth of 210.77% YoY in Q4 2025 is also a positive indicator.
Insider selling has increased significantly by 577.34% over the last month, which may signal a lack of confidence from within the company. Wolfe Research downgraded the stock, citing valuation concerns and weak patent strength. Net income and EPS have declined YoY, and gross margin has contracted.
In Q4 2025, revenue increased significantly by 210.77% YoY to $321.08 million, but net income dropped to -$58.58 million (-1.42% YoY), and EPS fell to -2.55 (-5.90% YoY). Gross margin also declined to 92.39% (-4.43% YoY), indicating some operational challenges despite revenue growth.
Analyst ratings are mixed. While Barclays and Piper Sandler have high price targets ($964 and $900, respectively), Wolfe Research downgraded the stock, citing valuation concerns. BofA has a Neutral stance and has lowered its price target twice recently, reflecting cautious sentiment.
